This clinical research study is evaluating an investigational medication, KarXT, for adults with Alzheimer’s disease who are experiencing agitation. The study is designed to assess the safety and effectiveness of the study medication compared with placebo.
Key Eligibility Criteria:
To pre-qualify for this study, an individual must:
- Be 55 to 90 years of age
- Have a diagnosis of Alzheimer’s disease
- Be experiencing agitation related to Alzheimer’s disease
- Have a caregiver who is able to attend study visits and help with study participation
- Meet additional study criteria
Some medications may not be allowed during the study. Additional medical and study requirements will be reviewed during screening.
Contact us or fill out the form below so we can reach out to you and move forward with pre-screening questions to assess your overall eligibility.